Cervical cancer is primarily caused by persistent infection with high-risk strains of the human papillomavirus (HPV). The HPV vaccine is a highly effective preventive measure, reducing the risk of cervical cancer by up to 90% when administered before exposure to the virus. The vaccine is recommended for girls and boys between 9 and 14 years old, though it can be given up to 45 years of age. Regular cervical screening through Pap smears and HPV testing further enhances prevention by detecting early cellular changes. Public awareness and timely vaccination are crucial in reducing cervical cancer rates globally. Dr. Munisha Sharma, practicing in DLF Phase 1, provides expert guidance and safe HPV vaccination for cervical cancer prevention.